1[1]Lai CL,Chien RN,Leung NW,et al.A one-year trail of lamivudine for chronic hepatitis B Asia Hepatitis lamivudine Study Group.N Engl J Med,1998,339:61-68
2[2]Dienstag JT,Schiff ER,Wright TL,et al.Lamivudine as a intial treatment for chronic hepatitis B in the United States.N Engl J Med,1999,341:1256-1263
3[3]Schiff ER,Karayalcin S,Grimm I,et al.A placebo controlled study of lamivudine and interferon alpha-2b in patients with chronic hepatitis B who previously failed interferon theraphy.[Abstract].International lamivudine investigator group.Hepatology,1998,28:388A
4[4]Leung N,Wu PC,Tsang S,et al.Continued histological improvement in Chinese patients with chronic hepatitis B with 2 years lamivudine[Abstract].Hepatology,1998,28:489A
5[5]Liaw YF,Lai CL,leung NW,et al.two years lamivudine therapy in chronic hepatitis B infection:results of a placebo controlled multicenter study in Asia.Gastroenterology,1998,114:1289-1292
6[6]Tassopoulos NC,Volpes R,Pastore G,et al.lamivudine therapy in patients with anti-HBe positive chronic hepatitis B:end of treatment analysis.J Hepatol,1998,28(suppl 1):43-45
7[7]Chien RN,Liaw YF,Atkins M,et al.Pretherapy alanine transaminase level as a determinant for hepatitis B e antigen seroconversion during lamivudine therapy in patients with chronic hepatitis B.Hepatology,1999,30(3):770-774
8[8]Lai CL,Ching CK,Tung AK,et al.Lamivudine is effective in suppressing hepatitis B virus DNA in chinese hepatitis B surface antigen carrier.Hepatology,1997,25(1):241-244
9[9]Lau DT; Doo E,Park Y,et al.lamivudine for chronic delta hepatitis.Hepatology,1999,30(2):546-549
10[10]Buti M,Cotrina M,Cruz de castro E,et al.One year treatment with lamivudine in different hepatitis B virus related hepatic diseases.Gastroenterol·Hepatol,1999,22(3):117-121
